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Abstract
Objective
One of the difficulties to conduct electroencephalography (EEG) in 
pediatric patient population is that they are not always cooperative 
during the procedure. Different medications are used to induce 
sedation during EEG recording. In order to find a medication with 
the least adverse effects and high efficacy; the current study aimed at 
comparing clonidine and chloral hydrate as a premedication prior to 
EEG recording in pediatric population. 
Materials & Methods
A prospective, randomized, single-blinded, controlled trial was 
conducted on 198 children (9 to 156 months old) to investigate the 
sedative and adverse effects of clonidine and chloral hydrate. Patients, 
partially sleep-deprived the night before, were randomly divided into 
two groups of clonidine (n=100) and chloral hydrate (n=98) on an 
alternative day basis.
Results
The average sleep onset latency was significantly longer in the 
clonidine group than chloral hydrate group (the Mann-Whitney test, 
p <0.0001). Sleep duration ranged 15 to 150 minutes and it was not 
significantly different between the two groups (the Mann-Whitney 
test, p = 0.2). Drowsiness terminated faster with chloral hydrate than 
clonidine.
Drowsiness after arousal was observed in 58% and 26.1% of patients in 
the clonidine and chloral hydrate groups, respectively; the difference 
between the groups was significant (the Mann-Whitney test, p = 
0.058). EEG results were reported normal in 77 subjects in the chloral 
hydrate group (77%) and 69 subjects (69%) in the clonidine group (p 
= 0.161). Generalized epileptiform discharges were significant in the 
clonidine group (the Mann-Whitney test, p = 0.006).
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Introduction
One of the difficulties to conduct 
electroencephalography (EEG) in pediatric 
population is that they are not always cooperative 
during the procedure. It is generally  agreed that 
most children undergoing medical procedures 
get frightened and uncooperative, and should be 
managed with behavioral and non-pharmacologic 
techniques. Unfortunately, a small percentage of 
pediatric patients cannot be successfully managed 
solely with such techniques (1). Several sedative-
hypnotic agents can be used in children for 
medical procedures including benzodiazepines, 
ketamine, hydroxyzine, melatonin, clonidine, 
chloral hydrate, sufentanil, dexmedetomidine, etc. 
Clonidine, an α-2 agonist, is suggested as an 
alternative agent for sleep induction in children. 
Mikawa et al. (1993), (2) concluded in a review 
study that clonidine, administered via oral, 
rectal, or caudal route is a promising adjunct to 
anesthetics and analgesics to enhance the quality 
of perioperative care in infants and children. 
Later publications also support the utilization of 
clonidine as premedication (3).
Chloral hydrate has some known adverse effects 
such as nausea, vomiting, agitation, ataxia, 
prolonged sedation, delayed apnea events, 
Conclusion
The results of the current study showed that both 5% chloral hydrate 
(1 mL/kg) and clonidine (4 μg/kg) could be administered as a 
premedication prior to EEG recording in children, although drowsiness 
after arousal was higher with clonidine than chloral hydrate. However, 
the yield of generalized epileptiform discharges in the clonidine group 
was greater than that of the chloral hydrate group. 
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gastric irritation, potential carcinogenicity, and 
genotoxicity even as a single low-dose (4–6). 
A number of previous studies compared sedative 
and adverse effects of some premedication such 
as midazolam, melatonin and chloral hydrate, but 
there is still a lack of studies on comparing clonidine 
with chloral hydrate. The current prospective, 
randomized, single-blinded, controlled trial aimed 
at comparing the sedative and adverse effects of 
clonidine and chloral hydrate.
Materials & Methods
The protocol of the current prospective study 
was approved by the Ethics Committee of Tehran 
University of Medical Sciences. Written and oral 
informed consent was obtained from parents 
prior to inclusion in the study. The current study 
was conducted over one year at a major pediatric 
university hospital in Tehran, Iran. The enrolled 
subjects were children within the age range of 9 
to 156 months scheduled for EEG recording in the 
center. The study had a randomized, single-blinded 
design; patients were randomly allocated to one of 
the two premedication options of oral clonidine or 
chloral hydrate.
The following data were obtained: age, gender, 
weight, EEG indication, underlying medical 
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conditions, and medication history. Information 
concerning clonidine and chloral hydrate included 
the dose, sleep onset time, sleep duration, time to 
arousal, efficacy, side effects, and complications. 
A trained staff filled out a questionnaire for each 
patient to collect the following data: neurological 
diagnosis, sleep onset latency, sleep duration, 
drowsiness time, and adverse events that occurred 
within the first four hours after EEG recording. 
The administered doses of clonidine and 5% chloral 
hydrate were 4 μg/kg and 1 mL/kg, respectively. 
Premedication was administered 30 minutes prior 
to EEG recording. An analog 21-channel Nihon 
Kohden EEG machine based on the standard 
international 10-20 system was  used. Two trained 
and skilled pediatric neurologists interpreted 
recorded EEGs.
 Patients who were thermodynamically unstable or 
had severe respiratory failure, patients with severe 
failure to thrive, infants younger than six months 
of age, the ones with a history of hypersensitivity 
to either clonidine or chloral hydrate, and those 
that their parents refused to provide consent were 
excluded. 
Statistical Analysis
Based on the literature, the required study sample 
size was 100 in each group (α= 0.05, β= 0.2). 
Data were analyzed for normal distribution using 
the Shapiro-Wilk test. Statistical analysis was 
performed using independent samples t-test and 
the Mann-Whitney-Wiloxon test for continuous 
data. Categorical variables were analyzed using the 
Fisher exact and Chi-squared tests. A P-value of 
<0.05 was considered significant. A biostatistician 
blinded to the study groups performed the statistical 
analysis.
Results
Totally, 198 pediatric patients were enrolled in the 
study; 81 females (40.7%) and 117 males (58.8%). 
The patients’ age ranged 9 to 156 months (mean 
± standard deviation (SD): 42.11 ±42.64 months). 
The two groups were matcher for gender. The 
clonidine group consisted of 58 (49.6%) males and 
42 (51.9%) females and the chloral hydrate group 
consisted of 59 (50.4%) males and 39 (48.1%) 
females (p = 0.75). The mean age of the subjects 
in the clonidine group was higher than that of 
the ones in the chloral hydrate group (57.4±30.5 
vs. 27± 21.8 months); the difference between the 
groups was significant (p >0.0005). 
EEG indications 
Top indication for referral for EEG in both groups 
was seizure disorders (84 (54.9%) subjects in the 
chloral hydrate and 76 (45.1%) patients in the 
clonidine groups); however, and the frequency 
of this etiology was not significantly different 
between the groups (p=0.116). Other indications 
were attention deficit hyperactivity disorder 
(ADHD) (2.5%), sleep disorders (0.5%), speech 
disorders (0.5%), and miscellaneous (11%). 
ADHD, as an indication for EEG, was observed 
only in the clonidine group (12 children vs. zero 
children) (p <0.001), but other etiologies were 
evenly distributed amongst subjects of both groups 
(p=0.05).
Efficacy of premedication 
The time gap between premedication and the start 
of sleep (sleep onset latency) varied from 9 to 
190 minutes in the studied subjects. The average 
sleep onset latency in the clonidine group was 
significantly longer than that of the chloral hydrate 
group (86 minutes and 17 seconds vs. 48 minutes 
and 48 seconds) (p <0.0001).
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Sleep duration in total subjects ranged 15 to 150 
minutes and there was no significant difference 
between the two medications (74 minutes and 12 
seconds for clonidine vs. 68 minutes and 8 seconds 
for chloral hydrate) (p = 0.2). 
For patients medicated with clonidine, it took longer 
to be wide awake (drowsiness time: 26 minutes 
and 13 seconds for the chloral hydrate group vs. 32 
minutes and 21 seconds for the clonidine group) (p 
<0.0001). Sleep characteristics of the two groups 
are provided in Figure 1.
Premedication adverse effects 
Unusual drowsiness occurred in 58 (58%) patients 
medicated with clonidine, while it was observed 
in 26 (26.1%) patients in the chloral hydrate group 
(p = 0.058). The only other adverse effect was 
vertigo, occurred in only 3% of patients medicated 
with clonidine. Other side effects such as nausea, 
vomiting, or agitation were not observed.
EEG interpretation
Recorded EEGs were twice interpreted by two 
trained and skilled pediatric neurologists. The EEG 
interpretations were similar in 70% of the cases. 
EEG results were reported normal in 77 subjects 
(77%) in the chloral hydrate group and 69 subjects 
(69%) in the clonidine group (p = 0.161). Focal 
epileptiform discharge and multifocal epileptiform 
discharge were not significantly different between 
the two groups (p = 0.74 and 0.2, respectively). 
The reports on the focal background disturbance, 
diffuse background disturbance, and fast activity 
in the two groups were not significantly different 
(p = 0.1, 0.15, and 0.15, respectively).  Generalized 
epileptiform discharge was reported in 14 subjects 
in the clonidine group and three subjects in the 
chloral group (p = 0.006).
Figure 1:  Sleep Characteristics in the Chloral Hydrate and Clonidine Groups
Recorded EEGs were twice interpreted by two trained and skilled pediatric 
neurologists. The EEG interpretations were similar in 70% of the cases. EEG 
results were reported normal in 77 subjects (77%) in the chloral hydrate group and 
69 subjects (69%) in the clonidine group (p = 0.161). Focal epileptiform discharge 
and multifocal epileptiform discharge were not significantly different between the 
two groups (p = 0.74 and 0.2, respectively). The rep rts on the focal background 
disturbance, diffuse background disturbance, and fast activity in the two groups 
were not significantly different (p = 0.1, 0.15, and 0.15, respectively).  Generalized 
epileptiform dis harge was rep rted in 14 subjects in the clonidine group and three 
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Discussion
Children undergoing EEG may experience 
significant anxiety and distress during the 
procedure, but the question whether routine 
premedication for children prior to EEG is 
necessary or not is currently under debate. 
Hatava and Olsson showed that pre-operative 
psychological preparation and the presence of 
parents were beneficial and could reduce the need 
for pharmacological premedication (7). However, 
sedative premedication with midazolam was 
more effective than either parental presence or no 
intervention at all to manage child/parent anxiety 
during the pre-operative period (8,9). According 
to these facts, researchers are looking for the best 
medication to induce sleep during EEG in children. 
An ideal medication for this goal should have rapid 
onset, long-acting sedative effect, low side effects, 
and the minimum impact on the EEG background 
(8). Benzodiazepines are drugs most widely used 
as premedication in pediatric anesthesia, and 
midazolam is at the top of the list of benzodiazepines 
used for induction of sedation in children (10). 
Midazolam, when used as the premedication in 
children, has a number of beneficial effects such as 
effective sedation, rapid onset, short acting, lower 
rate of vomiting, and less amnesia after sedation 
(11–13); although some paradoxical reactions such 
as agitation (14,15) and hypotonia (8) are observed 
following the utilization of midazolam in children.
Some studies were also performed to compare 
chloral hydrate and midazolam, chloral hydrate, 
and melatonin as premedication in children. 
Recently, clonidine is suggested by 
anesthesiologists for the induction of sedation 
before anesthesia. A study investigated the 
application of clonidine as a pre-anesthetic agent in 
the children undergoing surgery and indicated that 
oral clonidine was an effective premedication with 
few side effects (16). However, the current study 
suggests that further studies should be conducted to 
determine the optimal dosage and the safety of this 
drug in children. To the best of authors` knowledge, 
no studies compared clonidine and chloral hydrate 
for pediatric premedication, especially in children 
undergoing EEG.
This study designed for the  clinical advantages 
and disadvantages of oral clonidine in comparison 
with chloral hydrate as premedication prior to EEG 
recording in children. 
Several studies on premedication in the pediatric 
population showed that clonidine had slow onset 
of action (16,17,18). The current study finding 
on the clonidine onset of action was in agreement 
with those of the previous studies. Chloral hydrate 
induced sleep in the current study subjects faster 
than clonidine, although the sleep durations were 
similar in the two groups. The subjects medicated 
with clonidine had longer drowsiness period 
on average after the procedure compared to the 
ones medicated with chloral hydrate. The time 
of maintaining sedation with clonidine is long 
enough, which makes this drug a more suitable 
choice for premedication prior to EEG recording 
in pediatric patients. Other adverse effects such as 
nausea, vomiting, or seizure were not observed in 
any of the groups. In the current study, no agitation 
or hypotonia was  reported, similar to what was 
observed with midazolam previously.
In the current study, there was no significant 
difference in gender distribution between the two 
groups, although the mean age of the subjects in 
the clonidine group was higher.
One important factor as premedication agent in 
EEG recording is its impact on EEG interpretation. 
According to EEG results, normal EEG was 
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observed in 77% of the subjects in the chloral 
hydrate group versus 69% in the clonidine group, 
which the difference between the groups was 
not significant (p = 0.16). Other EEG findings 
such as focal epileptiform discharge, multifocal 
epileptiform discharge, focal background 
disturbance, multifocal background disturbance, 
generalized background disturbance, and rapid 
activity were not significantly different between the 
two groups. The only exception was generalized 
epileptiform discharge, which was significantly 
higher among the clonidine-medicated subjects 
and this meant a higher diagnostic yield of 
clonidine group. Clonidine also had no impacts on 
the background of EEG, unlike midazolam with 
rapid EEG activity and melatonin with generalized 
rapid beta activity followed by slow delta activity 
in temporal regions.
There were no significant differences in the 
indications of EEG between the two groups 
except for patients with ADHD, which the EEG 
technicians tended to administer clonidine to such 
cases.
Chloral hydrate induced sleep faster than clonidine, 
but the sleep duration was similar for subjects in the 
two groups. The subjects medicated with clonidine 
had longer drowsiness time on average compared 
to the ones medicated with chloral hydrate.
Longer drowsiness time in clonidine group was 
the only difference between drug adverse effects 
in two groups. Other drug adverse effects such as 
nausea, vomiting, agitation, or seizure were not 
observed in both  groups. Agitation and hypotonia 
that was reported in previous midazolam study 
was not seen in this study (16). Additionally, no 
respiratory failure or hypoxia was observed using 
these drugs, although  infants younger than six 
months of age were excluded from the study.
In Conclusion, Results of the current study 
showed that both 5% chloral hydrate (1 mL/kg) 
and clonidine (4 μg/kg) can be administered as a 
sedative agent prior to EEG recording in children. 
Clonidine with a high efficacy in inducing and 
maintaining sleep during EEG recording and 
minimal adverse effects can be one of the ideal 
choices for premedication prior to EEG recording 
in pediatric patients. The yield of generalized 
epileptiform discharges in the clonidine group was 
greater than that of the chloral hydrate group, with 
little confusing effects on EEG interpretation.
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